ENJP
CONTACT

News & Events

Dec 19, 2023
TOPICS

PassPort Technologies Commences Collaborative Research with Arcturus Therapeutics

PassPort Technologies(“PPTI”) commences collaborative research with Arcturus Therapeutics(“ARCT”). In this collaborative research, PPTI and ARCT combine their ground-breaking technologies, the transdermal drug delivery technology PassPort® system and the lipid-mediated delivery technology LUNAR®, to provide new options for mRNA vaccines and therapeutics. LUNAR® technology is the enabling technology used in Kostaive™, the first self-amplifying mRNA COVID vaccine in the world approved in Japan last month on November 28, 2023.

Contact

Please select the content of your inquiry.

PRIVACY POLICY